Healthcare Innovation

A new FDA-cleared device, born from a doctor's personal struggle with epilepsy, aims to prevent seizure injuries and is now widely accessible.

Kaiser Permanente hires veteran strategist Beth Leonard for a new C-suite role, signaling a major push to influence policy and export its care model.

As its single-dose glaucoma therapy nears trials, Diorasis adds a seasoned dealmaker to its board, signaling a strategic shift toward market entry.

With its first MASH drug a success, Madrigal aims to redefine treatment by combining it with a newly licensed Pfizer asset. Is this the future?

MiNK Therapeutics and UW–Madison launch a trial for an 'off-the-shelf' cell therapy, aiming to prevent deadly Graft-Versus-Host Disease (GvHD).

Atmus Filtration Technologies acquires Koch Filter for $450M in a major market expansion, while ADTi names a new CEO to lead a sharpened strategic focus.

Vera Therapeutics' novel IgAN drug gets FDA fast-track review, promising a new at-home treatment for a debilitating autoimmune kidney disease.

WK Kellogg Co is betting big on its first Super Bowl ad for Raisin Bran, using a mystery celebrity to spotlight a national health issue. Will it work?

A new $1,000 grant aims to foster compassion in future doctors, but its founder, a prominent psychiatrist, recently pleaded guilty to healthcare fraud.

With trial data showing an average 23% body weight loss, Novo Nordisk's new combination drug CagriSema could usher in a powerful new era for medicine.

Bolstered by positive clinical data and top investors, Kalaris Therapeutics extends its runway to advance TH103, a next-gen treatment for neovascular AMD.

New journalism awards tackle AI's risks and Indigenous health gaps, revealing how media innovation aims to build a healthier, more equitable Canada.

On Human Rights Day, Ottawa touts global leadership, but a chasm grows between its international promises and the stagnant progress on justice at home.